ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $251,000 | -8.7% | 20,175 | +0.5% | 0.00% | – |
| Q3 2016 | $275,000 | +96.4% | 20,075 | +5.7% | 0.00% | – |
| Q2 2016 | $140,000 | +29.6% | 18,985 | +12.4% | 0.00% | – |
| Q1 2016 | $108,000 | +0.9% | 16,885 | -1.7% | 0.00% | – |
| Q4 2015 | $107,000 | +4.9% | 17,185 | -1.2% | 0.00% | – |
| Q3 2015 | $102,000 | -28.2% | 17,385 | +1.2% | 0.00% | – |
| Q2 2015 | $142,000 | -0.7% | 17,185 | -1.2% | 0.00% | – |
| Q1 2015 | $143,000 | +22.2% | 17,385 | +1.8% | 0.00% | – |
| Q4 2014 | $117,000 | -4.9% | 17,085 | -25.0% | 0.00% | – |
| Q3 2014 | $123,000 | -56.8% | 22,785 | -49.0% | 0.00% | -100.0% |
| Q2 2014 | $285,000 | +137.5% | 44,685 | +200.2% | 0.00% | – |
| Q1 2014 | $120,000 | +17.6% | 14,885 | 0.0% | 0.00% | – |
| Q4 2013 | $102,000 | -64.7% | 14,885 | -5.1% | 0.00% | -100.0% |
| Q3 2013 | $289,000 | +4.0% | 15,685 | -1.3% | 0.00% | 0.0% |
| Q2 2013 | $278,000 | – | 15,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
| Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
| Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
| HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
| JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
| 1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
| Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
| Geduld E E | 185,100 | $1,157,000 | 0.72% |
| Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |